Last Update 22 May 26
Fair value Decreased 0.20%ICAD: Slower Healthcare Exit And Paused Special Payouts Will Shape Balanced Outlook
Analysts have nudged their fair value estimate for Icade slightly lower to about €21.31. This reflects a reduced price target and updated assumptions around slower revenue growth, a modestly softer profit margin, a higher discount rate and the view that asset disposals and potential special dividends may take longer to materialise.
Analyst Commentary
Bullish Takeaways
- Bullish analysts still see upside to the current fair value, with the latest external price target at €25, above the revised internal estimate of about €21.31.
- The planned disposal of the healthcare business is viewed as a potential catalyst for reshaping the portfolio. This could support a cleaner focus and clearer valuation once completed.
- The updated view that special dividends are no longer assumed in the next three years may give the company more flexibility to manage its balance sheet and future investments.
Bearish Takeaways
- Bearish analysts have shifted to a more neutral stance on the stock, with the rating moved to Equal Weight and the external price target trimmed from €30 to €25. This aligns with the recent reduction in fair value estimates.
- The longer expected timeline for the healthcare business disposal adds execution risk, as value from asset sales may take more time to be reflected in the share price.
- The removal of assumed special dividends over the next three years reduces the near term income appeal of the stock and places more emphasis on capital gains to drive total return.
- The combination of slower revenue growth assumptions, slightly softer margins and a higher discount rate signals greater caution around execution and risk. This is now reflected in valuation models.
What's in the News
- A special and extraordinary shareholders meeting is scheduled for June 10, 2026, for Icade in Paris La Défense, at Immeuble Coeur Défense, Tour B, Espace Comet, 24th floor, 100 Esplanade du Général de Gaulle, Paris La Défense Cedex, France (Key Developments).
- The meeting format combines special and extraordinary items, which can be relevant for decisions such as corporate structure changes, capital authorisations or governance adjustments, depending on the agenda that will be shared with shareholders (Key Developments).
- The location at the company’s Coeur Défense premises indicates an in person event, so shareholders may want to monitor any pre meeting documentation or resolutions published ahead of June 10, 2026 (Key Developments).
Valuation Changes
- Fair Value: Revised slightly lower from €21.35 to about €21.31 per share.
- Discount Rate: Risen slightly from 10.11% to about 10.18%, indicating a modestly higher required return in the model.
- Revenue Growth: Assumed annual revenue growth reduced from about 3.66% to about 1.77%, representing a material reset in growth expectations.
- Net Profit Margin: Trimmed from about 18.04% to about 17.31%, reflecting slightly lower projected profitability.
- Future P/E: Increased from about 7.96x to about 8.76x, implying a somewhat higher earnings multiple applied in the updated valuation.
Key Takeaways
- Diversification into resilient property segments and active capital recycling aim to strengthen revenue stability, boost occupancy, and drive portfolio performance.
- Strong ESG focus and operational efficiencies increase portfolio attractiveness, support higher net margins, and promote long-term earnings growth.
- Structural office market weaknesses, rising leverage, and stricter regulations are suppressing earnings and delaying recovery, with prolonged uncertainty affecting asset values, cash flow, and profitability.
Catalysts
About Icade- A full-service real estate company with expertise in both property investment (portfolio worth €6.4bn as of 12/31/2024 – 100% + Group share of joint ventures) and property development (2024 economic revenue of €1.2bn) that operates throughout France.
- Icade's active diversification into student housing, light industrial assets, and other resilient segments aligns with the growing demand driven by urban population growth and demographic changes in France, positioning the company to capture new rental income streams and improve revenue stability over the long term.
- The company's strategic focus on ESG and sustainable property development-including achievement of leading green certifications and a substantial share of green financing-makes Icade's portfolio increasingly attractive as tenants and investors prioritize energy efficiency and regulatory compliance, supporting higher occupancy rates and potentially enhanced net margins.
- The robust pipeline of office and mixed-use developments in prime, well-connected locations leverages shifting workplace dynamics and increasing tenant demand for affordable, modern workspace; this is expected to boost occupancy and future rental revenues as delivered assets come online.
- Asset rotation and disposal of non-core or mature assets at values in line with NAV demonstrate effective capital recycling and portfolio optimization, enabling reinvestment into higher-yielding sectors and supporting improvement in net margins and return on equity.
- Ongoing operational efficiencies, digital innovation, and cost discipline-evident in margin improvements within the development segment and stable average debt costs-are likely to reduce operating expenses and support long-term earnings growth and profitability.
Icade Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Icade's revenue will grow by 1.8% annually over the next 3 years.
- Analysts assume that profit margins will increase from -9.2% today to 17.3% in 3 years time.
- Analysts expect earnings to reach €243.9 million (and earnings per share of €3.28) by about May 2029, up from -€123.0 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 8.9x on those 2029 earnings, up from -12.7x today. This future PE is lower than the current PE for the GB REITs industry at 13.3x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 10.18%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Ongoing decline in rental and development revenues-Gross rental income in the Property Investment Division declined by 5% and Property Development revenue fell by 12% year-on-year, reflecting persistent market weakness and pressure on cash flow and earnings over the long term.
- Structural challenges in the office sector-High vacancy rates (above 10% in Greater Paris), tenant departures, negative reversion potential (minus 11%), and heavy tenant incentives indicate sustained oversupply and weak pricing power, likely leading to further asset value declines and suppressed rental income.
- Rising financial leverage and asset value risk-Loan-to-value ratio increased to 38.1% and NAV per share dropped 6% due to decreasing property values and limited disposals, increasing balance sheet vulnerability and the risk of further downgrades, with negative implications for net margins and future refinancing.
- Protracted recovery timelines amid cyclical and secular headwinds-Management expects meaningful cash flow and activity recovery only by 2027 due to persistent economic, political, and sector uncertainty, delaying the realization of new revenues and improvement in profitability.
- Increasing exposure to regulatory and structural risks-Intensifying ESG and energy efficiency requirements may demand costly upgrades across legacy assets, while the phasing out of supportive tax schemes (e.g., Pinel) limits development margins and investor demand, thereby compressing earnings over time.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €21.31 for Icade based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €33.4, and the most bearish reporting a price target of just €16.3.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €1.4 billion, earnings will come to €243.9 million, and it would be trading on a PE ratio of 8.9x, assuming you use a discount rate of 10.2%.
- Given the current share price of €20.6, the analyst price target of €21.31 is 3.3% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Icade?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.